WUXITECAN-2
Live / Applied — New application — not yet assigned to an examiner (as of 26 Mar 2026)
What this means for you
Not registered yet, but its 26 Mar 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99726259
- Mark type
- Stylized text
- Filed
- 26 Mar 2026
- Attorney of record
- Candice Reder
Goods and services
- Class 001 — Chemicals: Active chemical ingredients for use in the manufacture of pharmaceuticals; Chemical reagents, other than for medical or veterinary purpose; Biochemical catalysts; Biological preparations for use in the manufacture of pharmaceuticals; Chemical preparations for scientific purposes, other than for medical or veterinary use; Heterocyclic compounds; Chemical preparations for use in the manufacture of pharmaceuticals; Antibody reagents used for the detection of antigens in cells and tissue, other than for medical or veterinary purposes
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for inhibiting tumors; Pharmaceutical products for the prevention and treatment of cancer; Biological preparations for the treatment of cancer; Biological preparations for use in cell cultures for medical purposes; Chemical reagents for medical or veterinary purposes; Chemical reagents for medical purposes; Antibodies for medical purposes; Biologics in the nature of cells for the treatment of cancer
- Class 040 — Treatment of materials: Custom manufacture of pharmaceuticals; Custom manufacturing of pharmaceuticals; Manufacturing services for others in the field of antibody drug conjugates and intermediates thereof; Custom manufacture of pharmaceutical preparations, biomedical preparations, drug conjugates, anti-body drug conjugates, chemical reagents; Biomanufacturing for others of pharmaceuticals using biological organisms in the manufacturing process
- Class 042 — Scientific and technological services: Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Research and development services of new pharmaceutical products; Research and development of antibody-drug conjugates; Research and development of conjugated antibodies; Product development consulting in the field of pharmaceuticals, anti-bodies, conjugated antibodies, chemical reagents; Product development for others; Biomedical research services; Scientific research in the nature of conducting clinical trials for others in the field of new pharmaceutical development
Owner
- WuXi XDC Cayman Inc., Grand Cayman, KY
Prosecution history
- 26 Mar 2026 — APPLICATION FILING RECEIPT MAILED
- 26 Mar 2026 — NEW APPLICATION ENTERED